Market Trends of Global Hysteroscope Industry
This section covers the major market trends shaping the Hysteroscope Market according to our research experts:
Rigid Hysteroscope is Expected to Dominate the Market Over the Forecast Period
Rigid operative hysteroscopes are the diagnosis and surgery equipment that require assembly. Rigid Hysteroscopes are more durable than flexible hysteroscopes. The use of rigid hysteroscopes has increased recently as they allow both diagnosis and treatment. Rigid hysteroscopes are used in the treatment of various uterine abnormalities like removing polyps and fibroids and treating uterine cancer.
According to the National Health Service (NHS) 2022, around 2 in 3 women develop at least 1 fibroid at some point in life. They most often occur in women aged 30 to 50. It is more often seen in women of African-Caribbean origin. As the number of fibroid cases is significant, the demand for equipment for diagnosis and treatment will also increase. This factor is expected to increase the growth of rigid hysteroscopes.
Hence, owing to these factors, the rigid hysteroscope is expected to cover a large share of the hysteroscope market over the forecast period.
North America is Expected to Dominate the Market Over the Forecast Period
North America has developed countries with a well-structured healthcare system. As a result, the expenditure on research and development for equipment that is minimally invasive and more effective is also high. Also, the raise in uterine or endometrial cancers increases the demand for diagnosis using a hysteroscope.
According to the American Society of Clinical Oncology, Uterine Cancer: Statistics 2022, it is estimated that 65,950 people in the United States will be diagnosed with uterine, or endometrial, cancer in 2022. Also, as per the international journal of gynecology & obstetrics report titled "Cancer of the corpus uteri: 2021 update" published in October 2021, North America has the highest incidence of endometrial cancer, which is the most frequent cancer of the female genital tract, and the fifth most common site in women after breast, lung, colorectal, and non-basal skin cancer. Hence with the significant amount of Uterine or endometrial cancer cases, the demand for equipment for diagnosis and treatment for such illnesses will increase and helps in the growth of the market.
Furthermore, the new product approvals and launches help the segment to grow in the forecast period. For instance, in July 2021, Meditrina Inc launched their single-use Aveta Opal Hysteroscope and disposable Aveta Auto Resecting Device for removing soft endometrial tissue such as uterine polyps in an office setting, without the need for fluid management.
Hence, owing to these factors, North America is expected to cover a large share of the hysteroscope market.
